Abstract
Benz[e]indenes are tricyclic analogs of neuroactive steroids and can be modulators of GABAA receptor activity. We have examined the mechanisms of action of the benz[e]indene compound [3S-(3α,3aα,5aβ,7β,9aα,9bβ)]-dodecahydro-7-(2-hydroxyethyl)-3a-methyl-1H-benz[e]indene-3-carbonitrile (BI-2) using single-channel patch-clamp and whole-cell recordings from human embryonic kidney cells transfected with rat GABAA receptor α1, β2, and γ2L subunits. The data demonstrate that BI-2 is a positive modulator of GABAA receptor activity with a peak effect at 2 μM. The mechanism of modulation is similar but not identical to that of neuroactive steroids. Similar to steroids, BI-2 acts by prolonging the mean open time duration through an effect on the duration and prevalence of the longest open time component. However, in contrast to many steroids, BI-2 does not selectively reduce the channel closing rate. The potentiating action of BI-2 seems to be mediated through interactions with the classic neuroactive steroid binding site. Mutation to the membrane-spanning region in the α1 subunit Q242W and the double mutation α1N408A/Y411F, previously shown to abolish potentiation by neurosteroids, also diminish potentiation by BI-2. At higher concentrations (>5 μM), BI-2 inhibits receptor function by enhancing the apparent rate of desensitization. From single-channel recordings, we estimate that the entry rate into the inhibited or blocked state, k+B, is 0.50 μM-1 s-1. Based on the kinetic mechanism of action, and the finding that this effect is blocked by the α1V256S mutation, we propose that BI-2 acts through an inhibitory site first postulated for the inhibitory neurosteroid pregnenolone sulfate.
- Received January 16, 2006.
- Accepted March 22, 2006.
- The American Society for Pharmacology and Experimental Therapeutics
MolPharm articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|